uuid stringlengths 4 8 | template_uuid stringclasses 40
values | question stringlengths 13 193 | answer stringlengths 29 2.2k | benchmark_query stringlengths 133 622 | execution_results stringlengths 2 1.14M | query_type stringclasses 2
values | sql_category stringclasses 26
values | bio_category stringclasses 14
values |
|---|---|---|---|---|---|---|---|---|
Q59.1464 | Q59 | What is the genetic target of the small molecule drug Etonogestrel, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Etonogestrel is PGR. Etonogestrel reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%etonogestrel%" OR LOWER(tradeNames_string) LIKE "%etonogestrel%" OR ... | [{'UUID': 'DrugGeneTargets_v2_6181', 'drugName': 'Etonogestrel', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PGR (ENSG00000082175)', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1556 | Q59 | What is the genetic target of the small molecule drug Cabozantinib S-Malate, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Cabozantinib S-Malate: MET and KDR. Cabozantinib S-Malate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cabozantinib s-malate%" OR LOWER(tradeNames_string) LIKE "%cabozanti... | [{'UUID': 'DrugGeneTargets_v2_3579', 'drugName': 'Cabozantinib S-Malate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MET (ENSG00000105976), KDR (ENSG00000128052)', 'yearOfFirstApproval': 2012, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3580', 'drugName': 'C... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.708 | Q59 | What is the genetic target of the small molecule drug Diphenidol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Diphenidol is CHRM1. Diphenidol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%diphenidol%" OR LOWER(tradeNames_string) LIKE "%diphenidol%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_1476', 'drugName': 'Diphenidol Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM1 (ENSG00000168539)', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4667', 'drugName': 'Diphenidol', 'drugM... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1928 | Q59 | What is the genetic target of the small molecule drug Carbinoxamine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Carbinoxamine is HRH1. Carbinoxamine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%carbinoxamine%" OR LOWER(tradeNames_string) LIKE "%carbinoxamine%" O... | [{'UUID': 'DrugGeneTargets_v2_4593', 'drugName': 'Carbinoxamine Maleate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1625', 'drugName': 'Carbinoxamine', 'drugMo... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.614 | Q59 | What is the genetic target of the small molecule drug Ibandronate Sodium, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ibandronate Sodium is FDPS. Ibandronate Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ibandronate sodium%" OR LOWER(tradeNames_string) LIKE "%ibandronate ... | [{'UUID': 'DrugGeneTargets_v2_2230', 'drugName': 'Ibandronate Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'FDPS (ENSG00000160752)', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.372 | Q59 | What is the genetic target of the small molecule drug Varlitinib, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Varlitinib: ERBB2 and EGFR. Varlitinib reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%varlitinib%" OR LOWER(tradeNames_string) LIKE "%varlitinib%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_4435', 'drugName': 'Varlitinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ERBB2 (ENSG00000141736), EGFR (ENSG00000146648)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_4436', 'drugName': 'Varlitinib'... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1756 | Q59 | What is the genetic target of the small molecule drug Diethylstilbestrol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Diethylstilbestrol is ESR1. Diethylstilbestrol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%diethylstilbestrol%" OR LOWER(tradeNames_string) LIKE "%diethylstilb... | [{'UUID': 'DrugGeneTargets_v2_4689', 'drugName': 'Diethylstilbestrol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ESR1 (ENSG00000091831)', 'yearOfFirstApproval': 1973, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4127', 'drugName': 'Diethylstilbestrol Diphosp... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1669 | Q59 | What is the genetic target of the small molecule drug Jnj-42165279, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Jnj-42165279 is FAAH. Jnj-42165279 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%jnj-42165279%" OR LOWER(tradeNames_string) LIKE "%jnj-42165279%" OR ... | [{'UUID': 'DrugGeneTargets_v2_5455', 'drugName': 'Jnj-42165279', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'FAAH (ENSG00000117480)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.533 | Q59 | What is the genetic target of the small molecule drug Montelukast Sodium, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Montelukast Sodium is CYSLTR1. Montelukast Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%montelukast sodium%" OR LOWER(tradeNames_string) LIKE "%montelukast ... | [{'UUID': 'DrugGeneTargets_v2_2453', 'drugName': 'Montelukast Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CYSLTR1 (ENSG00000173198)', 'yearOfFirstApproval': 1998, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1821 | Q59 | What is the genetic target of the small molecule drug Caffeine, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Caffeine: ADORA1, ADORA2B, ADORA3, and ADORA2A. Caffeine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%caffeine%" OR LOWER(tradeNames_string) LIKE "%caffeine%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_4744', 'drugName': 'Caffeine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADORA1 (ENSG00000163485), ADORA2B (ENSG00000170425), ADORA3 (ENSG00000282608), ADORA2A (ENSG00000128271)', 'yearOfFirstApproval': 1948, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'U... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1442 | Q59 | What is the genetic target of the small molecule drug Cannabidiol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Cannabidiol is CNR1. Cannabidiol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cannabidiol%" OR LOWER(tradeNames_string) LIKE "%cannabidiol%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4055', 'drugName': 'Cannabidiol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CNR1 (ENSG00000118432)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.302 | Q59 | What is the genetic target of the small molecule drug Pergolide Mesylate, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the small molecule drug Pergolide Mesylate: DRD2, DRD3, DRD5, DRD4, and DRD1. Pergolide Mesylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pergolide mesylate%" OR LOWER(tradeNames_string) LIKE "%pergolide me... | [{'UUID': 'DrugGeneTargets_v2_6076', 'drugName': 'Pergolide Mesylate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), DRD3 (ENSG00000151577), DRD5 (ENSG00000169676), DRD4 (ENSG00000069696), DRD1 (ENSG00000184845)', 'yearOfFirstApproval': 1988, 'maxClinicalTrialPhase': 4, 'dru... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1016 | Q59 | What is the genetic target of the oligosaccharide drug Fondaparinux, and what is its status in clinical trials and FDA approval? | The genetic target of the oligosaccharide drug Fondaparinux is SERPINC1. Fondaparinux reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fondaparinux%" OR LOWER(tradeNames_string) LIKE "%fondaparinux%" OR ... | [{'UUID': 'DrugGeneTargets_v2_1957', 'drugName': 'Fondaparinux Sodium', 'drugMolecularType': 'Oligosaccharide', 'newLinkedTargets_string': 'SERPINC1 (ENSG00000117601)', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1756', 'drugName': 'Fondaparinux', 'drug... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1417 | Q59 | What is the genetic target of the antibody drug Talquetamab, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the antibody drug Talquetamab: GPRC5D, CD3E, CD3G, and CD3D. Talquetamab reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%talquetamab%" OR LOWER(tradeNames_string) LIKE "%talquetamab%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5924', 'drugName': 'Talquetamab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'GPRC5D (ENSG00000111291), CD3E (ENSG00000198851), CD3G (ENSG00000160654), CD3D (ENSG00000167286)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}, {'UUID': 'DrugGe... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1567 | Q59 | What is the genetic target of the oligonucleotide drug Custirsen, and what is its status in clinical trials and FDA approval? | The genetic target of the oligonucleotide drug Custirsen is CLU. Custirsen reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%custirsen%" OR LOWER(tradeNames_string) LIKE "%custirsen%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_2223', 'drugName': 'Custirsen Sodium', 'drugMolecularType': 'Oligonucleotide', 'newLinkedTargets_string': 'CLU (ENSG00000120885)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_5297', 'drugName': 'Custirsen', 'drugMolecularType... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1311 | Q59 | What is the genetic target of the protein drug Octreotide, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the protein drug Octreotide: SSTR5, SSTR2, SSTR4, SSTR1, and SSTR3. Octreotide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%octreotide%" OR LOWER(tradeNames_string) LIKE "%octreotide%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_759', 'drugName': 'Octreotide Acetate', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'SSTR5 (ENSG00000162009), SSTR2 (ENSG00000180616), SSTR4 (ENSG00000132671), SSTR1 (ENSG00000139874), SSTR3 (ENSG00000278195)', 'yearOfFirstApproval': 1988, 'maxClinicalTrialPhase': 4, 'drugIs... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.862 | Q59 | What is the genetic target of the small molecule drug Benoxinate Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Benoxinate Hydrochloride: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Benoxinate Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%benoxinate hydrochloride%" OR LOWER(tradeNames_string) LIKE "%benoxi... | [{'UUID': 'DrugGeneTargets_v2_2819', 'drugName': 'Benoxinate Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253), S... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.591 | Q59 | What is the genetic target of the small molecule drug Pimasertib, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Pimasertib: MAP2K1 and MAP2K2. Pimasertib reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pimasertib%" OR LOWER(tradeNames_string) LIKE "%pimasertib%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3059', 'drugName': 'Pimasertib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MAP2K1 (ENSG00000169032), MAP2K2 (ENSG00000126934)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_3060', 'drugName': 'Pimasert... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.485 | Q59 | What is the genetic target of the small molecule drug Ambrisentan, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Ambrisentan: EDNRB and EDNRA. Ambrisentan reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ambrisentan%" OR LOWER(tradeNames_string) LIKE "%ambrisentan%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3910', 'drugName': 'Ambrisentan', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'EDNRB (ENSG00000136160), EDNRA (ENSG00000151617)', 'yearOfFirstApproval': 2007, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1473 | Q59 | What is the genetic target of the small molecule drug Bfh-772, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Bfh-772 is KDR. Bfh-772 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bfh-772%" OR LOWER(tradeNames_string) LIKE "%bfh-772%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_2209', 'drugName': 'Bfh-772', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'KDR (ENSG00000128052)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1784 | Q59 | What is the genetic target of the antibody drug Ravagalimab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Ravagalimab is CD40LG. Ravagalimab reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ravagalimab%" OR LOWER(tradeNames_string) LIKE "%ravagalimab%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5736', 'drugName': 'Ravagalimab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'CD40LG (ENSG00000102245)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.644 | Q59 | What is the genetic target of the protein drug Trenibotulinumtoxine, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Trenibotulinumtoxine is SNAP25. Trenibotulinumtoxine reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%trenibotulinumtoxine%" OR LOWER(tradeNames_string) LIKE "%trenibotul... | [{'UUID': 'DrugGeneTargets_v2_2986', 'drugName': 'Trenibotulinumtoxine', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'SNAP25 (ENSG00000132639)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.357 | Q59 | What is the genetic target of the antibody drug Vixarelimab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Vixarelimab is OSMR. Vixarelimab reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%vixarelimab%" OR LOWER(tradeNames_string) LIKE "%vixarelimab%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3110', 'drugName': 'Vixarelimab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'OSMR (ENSG00000145623)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1128 | Q59 | What is the genetic target of the small molecule drug Doxycycline Hyclate, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Doxycycline Hyclate: MMP13, MMP1, MMP7, and MMP8. Doxycycline Hyclate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%doxycycline hyclate%" OR LOWER(tradeNames_string) LIKE "%doxycycline... | [{'UUID': 'DrugGeneTargets_v2_2400', 'drugName': 'Doxycycline Hyclate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MMP13 (ENSG00000137745), MMP1 (ENSG00000196611), MMP7 (ENSG00000137673), MMP8 (ENSG00000118113)', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.439 | Q59 | What is the genetic target of the small molecule drug Pomalidomide, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Pomalidomide: CRBN, DDB1, CUL4A, and RBX1. Pomalidomide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pomalidomide%" OR LOWER(tradeNames_string) LIKE "%pomalidomide%" OR ... | [{'UUID': 'DrugGeneTargets_v2_4886', 'drugName': 'Pomalidomide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CRBN (ENSG00000113851), DDB1 (ENSG00000167986), CUL4A (ENSG00000139842), RBX1 (ENSG00000100387)', 'yearOfFirstApproval': 2013, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1121 | Q59 | What is the genetic target of the small molecule drug Thiethylperazine Maleate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Thiethylperazine Maleate is DRD2. Thiethylperazine Maleate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%thiethylperazine maleate%" OR LOWER(tradeNames_string) LIKE "%thieth... | [{'UUID': 'DrugGeneTargets_v2_101', 'drugName': 'Thiethylperazine Maleate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295)', 'yearOfFirstApproval': 1961, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1103 | Q59 | What is the genetic target of the small molecule drug Belumosudil Mesylate, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Belumosudil Mesylate: ROCK2 and ROCK1. Belumosudil Mesylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%belumosudil mesylate%" OR LOWER(tradeNames_string) LIKE "%belumosudi... | [{'UUID': 'DrugGeneTargets_v2_6300', 'drugName': 'Belumosudil Mesylate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ROCK2 (ENSG00000134318), ROCK1 (ENSG00000067900)', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1348 | Q59 | What is the genetic target of the small molecule drug Haloperidol Decanoate, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Haloperidol Decanoate: DRD2, DRD3, DRD4, and HTR2A. Haloperidol Decanoate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%haloperidol decanoate%" OR LOWER(tradeNames_string) LIKE "%haloperid... | [{'UUID': 'DrugGeneTargets_v2_5257', 'drugName': 'Haloperidol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), DRD3 (ENSG00000151577), DRD4 (ENSG00000069696), HTR2A (ENSG00000102468)', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.597 | Q59 | What is the genetic target of the small molecule drug Azd1446, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Azd1446: CHRNB2 and CHRNA4. Azd1446 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%azd1446%" OR LOWER(tradeNames_string) LIKE "%azd1446%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_4875', 'drugName': 'Azd1446', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRNB2 (ENSG00000160716), CHRNA4 (ENSG00000101204)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1368 | Q59 | What is the genetic target of the protein drug Abarelix, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Abarelix is GNRHR. Abarelix reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%abarelix%" OR LOWER(tradeNames_string) LIKE "%abarelix%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_4834', 'drugName': 'Abarelix', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GNRHR (ENSG00000109163)', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1401 | Q59 | What is the genetic target of the small molecule drug Oxybutynin, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Oxybutynin: CHRM3 and CHRM2. Oxybutynin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%oxybutynin%" OR LOWER(tradeNames_string) LIKE "%oxybutynin%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3', 'drugName': 'Oxybutynin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM3 (ENSG00000133019), CHRM2 (ENSG00000181072)', 'yearOfFirstApproval': 1975, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2', 'drugName': 'Oxybutynin', '... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.753 | Q59 | What is the genetic target of the small molecule drug Cep-37440, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Cep-37440: ALK and PTK2. Cep-37440 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cep-37440%" OR LOWER(tradeNames_string) LIKE "%cep-37440%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_4475', 'drugName': 'Cep-37440', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ALK (ENSG00000171094), PTK2 (ENSG00000169398)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_4476', 'drugName': 'Cep-37440', 'd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.259 | Q59 | What is the genetic target of the antibody drug Bimagrumab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Bimagrumab is ACVR2B. Bimagrumab reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bimagrumab%" OR LOWER(tradeNames_string) LIKE "%bimagrumab%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_299', 'drugName': 'Bimagrumab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'ACVR2B (ENSG00000114739)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1687 | Q59 | What is the genetic target of the antibody drug Fazpilodemab, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the antibody drug Fazpilodemab: FGF1 and KLB. Fazpilodemab reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fazpilodemab%" OR LOWER(tradeNames_string) LIKE "%fazpilodemab%" OR ... | [{'UUID': 'DrugGeneTargets_v2_1258', 'drugName': 'Fazpilodemab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'FGF1 (ENSG00000113578), KLB (ENSG00000134962)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1723 | Q59 | What is the genetic target of the antibody drug Ozanezumab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Ozanezumab is RTN4. Ozanezumab reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ozanezumab%" OR LOWER(tradeNames_string) LIKE "%ozanezumab%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_6319', 'drugName': 'Ozanezumab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'RTN4 (ENSG00000115310)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.544 | Q59 | What is the genetic target of the small molecule drug Arsenic Trioxide, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Arsenic Trioxide is TXNRD1. Arsenic Trioxide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%arsenic trioxide%" OR LOWER(tradeNames_string) LIKE "%arsenic trioxi... | [{'UUID': 'DrugGeneTargets_v2_975', 'drugName': 'Arsenic Trioxide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TXNRD1 (ENSG00000198431)', 'yearOfFirstApproval': 2000, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.792 | Q59 | What is the genetic target of the small molecule drug Edasalonexent, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Edasalonexent: NFKB2, NFKB1, and RELA. Edasalonexent reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%edasalonexent%" OR LOWER(tradeNames_string) LIKE "%edasalonexent%" O... | [{'UUID': 'DrugGeneTargets_v2_1568', 'drugName': 'Edasalonexent', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NFKB2 (ENSG00000077150), NFKB1 (ENSG00000109320), RELA (ENSG00000173039)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1484 | Q59 | What is the genetic target of the protein drug Histrelin Acetate, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Histrelin Acetate is GNRHR. Histrelin Acetate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%histrelin acetate%" OR LOWER(tradeNames_string) LIKE "%histrelin ace... | [{'UUID': 'DrugGeneTargets_v2_3420', 'drugName': 'Histrelin Acetate', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GNRHR (ENSG00000109163)', 'yearOfFirstApproval': 1991, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.420 | Q59 | What is the genetic target of the antibody drug Vantictumab, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the antibody drug Vantictumab: FZD2, FZD7, FZD1, FZD5, and FZD8. Vantictumab reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%vantictumab%" OR LOWER(tradeNames_string) LIKE "%vantictumab%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5828', 'drugName': 'Vantictumab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'FZD2 (ENSG00000180340), FZD7 (ENSG00000155760), FZD1 (ENSG00000157240), FZD5 (ENSG00000163251), FZD8 (ENSG00000177283)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': Fa... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1849 | Q59 | What is the genetic target of the small molecule drug Venlafaxine, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Venlafaxine: SLC6A4 and SLC6A2. Venlafaxine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%venlafaxine%" OR LOWER(tradeNames_string) LIKE "%venlafaxine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1438', 'drugName': 'Desvenlafaxine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A2 (ENSG00000103546), SLC6A4 (ENSG00000108576)', 'yearOfFirstApproval': 2008, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5873', 'drugName': 'De... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1920 | Q59 | What is the genetic target of the small molecule drug Pantoprazole, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Pantoprazole: ATP4A and ATP4B. Pantoprazole reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pantoprazole%" OR LOWER(tradeNames_string) LIKE "%pantoprazole%" OR ... | [{'UUID': 'DrugGeneTargets_v2_1903', 'drugName': 'Pantoprazole Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ATP4A (ENSG00000105675), ATP4B (ENSG00000186009)', 'yearOfFirstApproval': 2000, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4835', 'drugName': ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1099 | Q59 | What is the genetic target of the protein drug Pegvisomant, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Pegvisomant is GHR. Pegvisomant reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pegvisomant%" OR LOWER(tradeNames_string) LIKE "%pegvisomant%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1805', 'drugName': 'Pegvisomant', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GHR (ENSG00000112964)', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.845 | Q59 | What is the genetic target of the small molecule drug Canrenone, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Canrenone is NR3C2. Canrenone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%canrenone%" OR LOWER(tradeNames_string) LIKE "%canrenone%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_82', 'drugName': 'Canrenoate Potassium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C2 (ENSG00000151623)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4514', 'drugName': 'Canrenone', 'drugMolecularTy... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.68 | Q59 | What is the genetic target of the small molecule drug Mardepodect, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Mardepodect is PDE10A. Mardepodect reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mardepodect%" OR LOWER(tradeNames_string) LIKE "%mardepodect%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4386', 'drugName': 'Mardepodect', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PDE10A (ENSG00000112541)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1698 | Q59 | What is the genetic target of the small molecule drug Nandrolone Decanoate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Nandrolone Decanoate is AR. Nandrolone Decanoate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nandrolone decanoate%" OR LOWER(tradeNames_string) LIKE "%nandrolone... | [{'UUID': 'DrugGeneTargets_v2_5812', 'drugName': 'Nandrolone Decanoate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AR (ENSG00000169083)', 'yearOfFirstApproval': 1983, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1733 | Q59 | What is the genetic target of the small molecule drug Glafenine, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Glafenine: PTGS2 and PTGS1. Glafenine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%glafenine%" OR LOWER(tradeNames_string) LIKE "%glafenine%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_579', 'drugName': 'Glafenine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.380 | Q59 | What is the genetic target of the small molecule drug Fosnetupitant Chloride Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Fosnetupitant Chloride Hydrochloride is TACR1. Fosnetupitant Chloride Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fosnetupitant chloride hydrochloride%" OR LOWER(tradeNames_string) L... | [{'UUID': 'DrugGeneTargets_v2_4376', 'drugName': 'Fosnetupitant Chloride Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TACR1 (ENSG00000115353)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.240 | Q59 | What is the genetic target of the small molecule drug Sotalol Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Sotalol Hydrochloride: ADRB1, KCNH2, and ADRB2. Sotalol Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%sotalol hydrochloride%" OR LOWER(tradeNames_string) LIKE "%sotalol h... | [{'UUID': 'DrugGeneTargets_v2_4569', 'drugName': 'Sotalol Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB1 (ENSG00000043591), KCNH2 (ENSG00000055118), ADRB2 (ENSG00000169252)', 'yearOfFirstApproval': 1992, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTar... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.257 | Q59 | What is the genetic target of the small molecule drug Prasugrel, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Prasugrel is P2RY12. Prasugrel reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%prasugrel%" OR LOWER(tradeNames_string) LIKE "%prasugrel%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_2823', 'drugName': 'Prasugrel Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'P2RY12 (ENSG00000169313)', 'yearOfFirstApproval': 2009, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3169', 'drugName': 'Prasugrel', 'drugMo... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1032 | Q59 | What is the genetic target of the small molecule drug Laropiprant, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Laropiprant is PTGDR. Laropiprant reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%laropiprant%" OR LOWER(tradeNames_string) LIKE "%laropiprant%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1831', 'drugName': 'Laropiprant', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGDR (ENSG00000168229)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.30 | Q59 | What is the genetic target of the small molecule drug Acrivastine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Acrivastine is HRH1. Acrivastine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%acrivastine%" OR LOWER(tradeNames_string) LIKE "%acrivastine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_2524', 'drugName': 'Acrivastine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1994, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.293 | Q59 | What is the genetic target of the small molecule drug Omeprazole Magnesium, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Omeprazole Magnesium: ATP4A and ATP4B. Omeprazole Magnesium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%omeprazole magnesium%" OR LOWER(tradeNames_string) LIKE "%omeprazole... | [{'UUID': 'DrugGeneTargets_v2_4440', 'drugName': 'Esomeprazole Magnesium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ATP4A (ENSG00000105675), ATP4B (ENSG00000186009)', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3369', 'drugName... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1886 | Q59 | What is the genetic target of the small molecule drug Pg-760564, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Pg-760564 is MAPK14. Pg-760564 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pg-760564%" OR LOWER(tradeNames_string) LIKE "%pg-760564%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_2205', 'drugName': 'Pg-760564', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MAPK14 (ENSG00000112062)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1823 | Q59 | What is the genetic target of the small molecule drug Fluoxetine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Fluoxetine is SLC6A4. Fluoxetine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fluoxetine%" OR LOWER(tradeNames_string) LIKE "%fluoxetine%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_4711', 'drugName': 'Fluoxetine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A4 (ENSG00000108576)', 'yearOfFirstApproval': 1987, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4447', 'drugName': 'Fluoxetine', 'drug... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.620 | Q59 | What is the genetic target of the small molecule drug Esketamine Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 7 genetic targets of the small molecule drug Esketamine Hydrochloride: GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3B, GRIN2C, and GRIN3A. Esketamine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%esketamine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%esketa... | [{'UUID': 'DrugGeneTargets_v2_817', 'drugName': 'Esketamine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GRIN1 (ENSG00000176884), GRIN2A (ENSG00000183454), GRIN2B (ENSG00000273079), GRIN2D (ENSG00000105464), GRIN3B (ENSG00000116032), GRIN2C (ENSG00000161509), GRIN3A (ENSG0000019878... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1667 | Q59 | What is the genetic target of the small molecule drug Forodesine Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Forodesine Hydrochloride is PNP. Forodesine Hydrochloride reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%forodesine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%forode... | [{'UUID': 'DrugGeneTargets_v2_5700', 'drugName': 'Forodesine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PNP (ENSG00000198805)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.850 | Q59 | What is the genetic target of the small molecule drug Apomorphine, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Apomorphine: DRD2, DRD3, and DRD4. Apomorphine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%apomorphine%" OR LOWER(tradeNames_string) LIKE "%apomorphine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3259', 'drugName': 'Apomorphine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), DRD3 (ENSG00000151577), DRD4 (ENSG00000069696)', 'yearOfFirstApproval': 2004, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3300'... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.215 | Q59 | What is the genetic target of the protein drug Setmelanotide, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Setmelanotide is MC4R. Setmelanotide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%setmelanotide%" OR LOWER(tradeNames_string) LIKE "%setmelanotide%" O... | [{'UUID': 'DrugGeneTargets_v2_689', 'drugName': 'Setmelanotide', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'MC4R (ENSG00000166603)', 'yearOfFirstApproval': 2020, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2878', 'drugName': 'Setmelanotide Acetate', 'drugMolecularT... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.524 | Q59 | What is the genetic target of the small molecule drug Fluphenazine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Fluphenazine is DRD2. Fluphenazine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fluphenazine%" OR LOWER(tradeNames_string) LIKE "%fluphenazine%" OR ... | [{'UUID': 'DrugGeneTargets_v2_905', 'drugName': 'Fluphenazine Enanthate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295)', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4664', 'drugName': 'Fluphenazine', 'drugMol... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.477 | Q59 | What is the genetic target of the small molecule drug Irinotecan, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Irinotecan is TOP1. Irinotecan reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%irinotecan%" OR LOWER(tradeNames_string) LIKE "%irinotecan%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_5193', 'drugName': 'Irinotecan Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TOP1 (ENSG00000198900)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4299', 'drugName': 'Irinotecan', 'drugMo... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1327 | Q59 | What is the genetic target of the small molecule drug Biperiden Lactate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Biperiden Lactate is CHRM1. Biperiden Lactate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%biperiden lactate%" OR LOWER(tradeNames_string) LIKE "%biperiden lac... | [{'UUID': 'DrugGeneTargets_v2_6214', 'drugName': 'Biperiden Lactate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM1 (ENSG00000168539)', 'yearOfFirstApproval': 1961, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1433 | Q59 | What is the genetic target of the small molecule drug Phenylephrine Bitartrate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Phenylephrine Bitartrate: ADRA1A, ADRA1D, and ADRA1B. Phenylephrine Bitartrate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%phenylephrine bitartrate%" OR LOWER(tradeNames_string) LIKE "%phenyl... | [{'UUID': 'DrugGeneTargets_v2_2414', 'drugName': 'Phenylephrine Bitartrate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214)', 'yearOfFirstApproval': 1973, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.123 | Q59 | What is the genetic target of the small molecule drug Dimethindene, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Dimethindene is HRH1. Dimethindene reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dimethindene%" OR LOWER(tradeNames_string) LIKE "%dimethindene%" OR ... | [{'UUID': 'DrugGeneTargets_v2_588', 'drugName': 'Dimethindene', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1351 | Q59 | What is the genetic target of the small molecule drug Ccx354, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ccx354 is CCR1. Ccx354 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ccx354%" OR LOWER(tradeNames_string) LIKE "%ccx354%" OR LOWER(drugSy... | [{'UUID': 'DrugGeneTargets_v2_200', 'drugName': 'Ccx354', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CCR1 (ENSG00000163823)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1942 | Q59 | What is the genetic target of the small molecule drug Mavelertinib, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Mavelertinib is EGFR. Mavelertinib reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mavelertinib%" OR LOWER(tradeNames_string) LIKE "%mavelertinib%" OR ... | [{'UUID': 'DrugGeneTargets_v2_6168', 'drugName': 'Mavelertinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'EGFR (ENSG00000146648)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1371 | Q59 | What is the genetic target of the small molecule drug Doxepin Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Doxepin Hydrochloride is SLC6A2. Doxepin Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%doxepin hydrochloride%" OR LOWER(tradeNames_string) LIKE "%doxepin h... | [{'UUID': 'DrugGeneTargets_v2_2495', 'drugName': 'Doxepin Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A2 (ENSG00000103546)', 'yearOfFirstApproval': 1969, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1171 | Q59 | What is the genetic target of the small molecule drug Ranitidine Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ranitidine Hydrochloride is HRH2. Ranitidine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ranitidine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%raniti... | [{'UUID': 'DrugGeneTargets_v2_1617', 'drugName': 'Ranitidine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH2 (ENSG00000113749)', 'yearOfFirstApproval': 1983, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.138 | Q59 | What is the genetic target of the protein drug Barusiban, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Barusiban is OXTR. Barusiban reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%barusiban%" OR LOWER(tradeNames_string) LIKE "%barusiban%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1521', 'drugName': 'Barusiban', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'OXTR (ENSG00000180914)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1134 | Q59 | What is the genetic target of the small molecule drug Telratolimod, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Telratolimod: TLR8 and TLR7. Telratolimod reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%telratolimod%" OR LOWER(tradeNames_string) LIKE "%telratolimod%" OR ... | [{'UUID': 'DrugGeneTargets_v2_5246', 'drugName': 'Telratolimod', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TLR8 (ENSG00000101916), TLR7 (ENSG00000196664)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_5247', 'drugName': 'Telratolim... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1874 | Q59 | What is the genetic target of the small molecule drug Morphine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Morphine is OPRM1. Morphine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%morphine%" OR LOWER(tradeNames_string) LIKE "%morphine%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_3300', 'drugName': 'Apomorphine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), DRD3 (ENSG00000151577), DRD4 (ENSG00000069696)', 'yearOfFirstApproval': 2004, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTa... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1241 | Q59 | What is the genetic target of the small molecule drug Cisatracurium, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the small molecule drug Cisatracurium: CHRNA1, CHRNG, CHRNB1, CHRND, and CHRNE. Cisatracurium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cisatracurium%" OR LOWER(tradeNames_string) LIKE "%cisatracurium%" O... | [{'UUID': 'DrugGeneTargets_v2_3167', 'drugName': 'Cisatracurium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRNA1 (ENSG00000138435), CHRNG (ENSG00000196811), CHRNB1 (ENSG00000170175), CHRND (ENSG00000135902), CHRNE (ENSG00000108556)', 'yearOfFirstApproval': 1995, 'maxClinicalTrialPhase': 4, 'd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1338 | Q59 | What is the genetic target of the small molecule drug Methamphetamine Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Methamphetamine Hydrochloride: SLC6A4, SLC6A3, and SLC6A2. Methamphetamine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%methamphetamine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%m... | [{'UUID': 'DrugGeneTargets_v2_5557', 'drugName': 'Methamphetamine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A4 (ENSG00000108576), SLC6A3 (ENSG00000142319), SLC6A2 (ENSG00000103546)', 'yearOfFirstApproval': 1943, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.958 | Q59 | What is the genetic target of the small molecule drug Thioguanine, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Thioguanine: IMPDH1 and IMPDH2. Thioguanine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%thioguanine%" OR LOWER(tradeNames_string) LIKE "%thioguanine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5258', 'drugName': 'Thioguanine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'IMPDH1 (ENSG00000106348), IMPDH2 (ENSG00000178035)', 'yearOfFirstApproval': 1966, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.929 | Q59 | What is the genetic target of the small molecule drug Trihexyphenidyl, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Trihexyphenidyl is CHRM1. Trihexyphenidyl reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%trihexyphenidyl%" OR LOWER(tradeNames_string) LIKE "%trihexyphenidyl... | [{'UUID': 'DrugGeneTargets_v2_6217', 'drugName': 'Trihexyphenidyl', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM1 (ENSG00000168539)', 'yearOfFirstApproval': 1949, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6050', 'drugName': 'Trihexyphenidyl Hydrochlorid... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.112 | Q59 | What is the genetic target of the small molecule drug Synthetic Conjugated Estrogens, B, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Synthetic Conjugated Estrogens, B: ESR2 and ESR1. Synthetic Conjugated Estrogens, B reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%synthetic conjugated estrogens, b%" OR LOWER(tradeNames_string) LIKE... | [{'UUID': 'DrugGeneTargets_v2_4209', 'drugName': 'Synthetic Conjugated Estrogens, B', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ESR2 (ENSG00000140009), ESR1 (ENSG00000091831)', 'yearOfFirstApproval': 2004, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1240 | Q59 | What is the genetic target of the small molecule drug Pentolinium Tartrate, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Pentolinium Tartrate: CHRNB4 and CHRNA3. Pentolinium Tartrate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pentolinium tartrate%" OR LOWER(tradeNames_string) LIKE "%pentoliniu... | [{'UUID': 'DrugGeneTargets_v2_4468', 'drugName': 'Pentolinium Tartrate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRNB4 (ENSG00000117971), CHRNA3 (ENSG00000080644)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1921 | Q59 | What is the genetic target of the protein drug Ceruletide Diethylamine, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Ceruletide Diethylamine is CCKAR. Ceruletide Diethylamine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ceruletide diethylamine%" OR LOWER(tradeNames_string) LIKE "%cerulet... | [{'UUID': 'DrugGeneTargets_v2_3461', 'drugName': 'Ceruletide Diethylamine', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'CCKAR (ENSG00000163394)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1963 | Q59 | What is the genetic target of the small molecule drug Netarsudil Dimesylate, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Netarsudil Dimesylate: ROCK2 and ROCK1. Netarsudil Dimesylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%netarsudil dimesylate%" OR LOWER(tradeNames_string) LIKE "%netarsudi... | [{'UUID': 'DrugGeneTargets_v2_4693', 'drugName': 'Netarsudil Dimesylate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ROCK2 (ENSG00000134318), ROCK1 (ENSG00000067900)', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.214 | Q59 | What is the genetic target of the small molecule drug Paricalcitol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Paricalcitol is VDR. Paricalcitol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%paricalcitol%" OR LOWER(tradeNames_string) LIKE "%paricalcitol%" OR ... | [{'UUID': 'DrugGeneTargets_v2_2779', 'drugName': 'Paricalcitol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'VDR (ENSG00000111424)', 'yearOfFirstApproval': 1998, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.999 | Q59 | What is the genetic target of the small molecule drug Propiomazine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Propiomazine is HRH1. Propiomazine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%propiomazine%" OR LOWER(tradeNames_string) LIKE "%propiomazine%" OR ... | [{'UUID': 'DrugGeneTargets_v2_518', 'drugName': 'Propiomazine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1960, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3422', 'drugName': 'Propiomazine Hydrochloride', 'dru... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1269 | Q59 | What is the genetic target of the small molecule drug Iobenguane I 131, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Iobenguane I 131 is SLC6A2. Iobenguane I 131 reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%iobenguane i 131%" OR LOWER(tradeNames_string) LIKE "%iobenguane i 1... | [{'UUID': 'DrugGeneTargets_v2_5267', 'drugName': 'Iobenguane I 131', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A2 (ENSG00000103546)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.592 | Q59 | What is the genetic target of the small molecule drug Rosuvastatin Calcium, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Rosuvastatin Calcium is HMGCR. Rosuvastatin Calcium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rosuvastatin calcium%" OR LOWER(tradeNames_string) LIKE "%rosuvastat... | [{'UUID': 'DrugGeneTargets_v2_5208', 'drugName': 'Rosuvastatin Calcium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HMGCR (ENSG00000113161)', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1391 | Q59 | What is the genetic target of the small molecule drug Trilaciclib Dihydrochloride, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Trilaciclib Dihydrochloride: CDK6 and CDK4. Trilaciclib Dihydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%trilaciclib dihydrochloride%" OR LOWER(tradeNames_string) LIKE "%tri... | [{'UUID': 'DrugGeneTargets_v2_3859', 'drugName': 'Trilaciclib Dihydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CDK6 (ENSG00000105810), CDK4 (ENSG00000135446)', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3860', 'drugN... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1450 | Q59 | What is the genetic target of the small molecule drug Desoxycorticosterone Acetate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Desoxycorticosterone Acetate is NR3C2. Desoxycorticosterone Acetate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%desoxycorticosterone acetate%" OR LOWER(tradeNames_string) LIKE "%de... | [{'UUID': 'DrugGeneTargets_v2_184', 'drugName': 'Desoxycorticosterone Acetate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C2 (ENSG00000151623)', 'yearOfFirstApproval': 1939, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.279 | Q59 | What is the genetic target of the small molecule drug Nicardipine Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Nicardipine Hydrochloride: CACNA1C, CACNA1S, CACNA1D, and CACNA1F. Nicardipine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nicardipine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%nicar... | [{'UUID': 'DrugGeneTargets_v2_320', 'drugName': 'Nicardipine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CACNA1C (ENSG00000151067), CACNA1S (ENSG00000081248), CACNA1D (ENSG00000157388), CACNA1F (ENSG00000102001)', 'yearOfFirstApproval': 1988, 'maxClinicalTrialPhase': 4, 'drugIsApp... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1507 | Q59 | What is the genetic target of the small molecule drug Promazine, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Promazine: DRD2, DRD3, DRD4, and HTR2A. Promazine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%promazine%" OR LOWER(tradeNames_string) LIKE "%promazine%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_3300', 'drugName': 'Apomorphine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), DRD3 (ENSG00000151577), DRD4 (ENSG00000069696)', 'yearOfFirstApproval': 2004, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTa... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1328 | Q59 | What is the genetic target of the small molecule drug Trelagliptin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Trelagliptin is DPP4. Trelagliptin reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%trelagliptin%" OR LOWER(tradeNames_string) LIKE "%trelagliptin%" OR ... | [{'UUID': 'DrugGeneTargets_v2_707', 'drugName': 'Trelagliptin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DPP4 (ENSG00000197635)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_3478', 'drugName': 'Trelagliptin Succinate', 'drugMolec... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1271 | Q59 | What is the genetic target of the small molecule drug Dextrothyroxine Sodium, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Dextrothyroxine Sodium: THRA and THRB. Dextrothyroxine Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dextrothyroxine sodium%" OR LOWER(tradeNames_string) LIKE "%dextroth... | [{'UUID': 'DrugGeneTargets_v2_4368', 'drugName': 'Dextrothyroxine Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'THRA (ENSG00000126351), THRB (ENSG00000151090)', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1820 | Q59 | What is the genetic target of the protein drug Pasireotide Pamoate, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the protein drug Pasireotide Pamoate: SSTR3, SSTR5, SSTR2, and SSTR1. Pasireotide Pamoate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pasireotide pamoate%" OR LOWER(tradeNames_string) LIKE "%pasireotide... | [{'UUID': 'DrugGeneTargets_v2_6121', 'drugName': 'Pasireotide Pamoate', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'SSTR3 (ENSG00000278195), SSTR5 (ENSG00000162009), SSTR2 (ENSG00000180616), SSTR1 (ENSG00000139874)', 'yearOfFirstApproval': 2014, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUI... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.273 | Q59 | What is the genetic target of the protein drug Cenegermin, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the protein drug Cenegermin: NTRK1, NTRK2, and NTRK3. Cenegermin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cenegermin%" OR LOWER(tradeNames_string) LIKE "%cenegermin%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3786', 'drugName': 'Cenegermin', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'NTRK1 (ENSG00000198400), NTRK2 (ENSG00000148053), NTRK3 (ENSG00000140538)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1863 | Q59 | What is the genetic target of the small molecule drug Entrectinib, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the small molecule drug Entrectinib: ROS1, ALK, NTRK1, NTRK2, and NTRK3. Entrectinib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%entrectinib%" OR LOWER(tradeNames_string) LIKE "%entrectinib%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1203', 'drugName': 'Entrectinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ROS1 (ENSG00000047936), ALK (ENSG00000171094), NTRK1 (ENSG00000198400), NTRK2 (ENSG00000148053), NTRK3 (ENSG00000140538)', 'yearOfFirstApproval': 2019, 'maxClinicalTrialPhase': 4, 'drugIsAp... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.578 | Q59 | What is the genetic target of the small molecule drug Fentanyl, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Fentanyl is OPRM1. Fentanyl reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fentanyl%" OR LOWER(tradeNames_string) LIKE "%fentanyl%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_3916', 'drugName': 'Fentanyl Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRM1 (ENSG00000112038)', 'yearOfFirstApproval': 2006, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_733', 'drugName': 'Fentanyl Citrate', 'dr... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.638 | Q59 | What is the genetic target of the small molecule drug Cobiprostone, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Cobiprostone is CLCN2. Cobiprostone reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cobiprostone%" OR LOWER(tradeNames_string) LIKE "%cobiprostone%" OR ... | [{'UUID': 'DrugGeneTargets_v2_581', 'drugName': 'Cobiprostone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CLCN2 (ENSG00000114859)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.713 | Q59 | What is the genetic target of the small molecule drug Dyphylline, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the small molecule drug Dyphylline: PDE4A, PDE4D, PDE4B, PDE4C, and PDE3A. Dyphylline reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dyphylline%" OR LOWER(tradeNames_string) LIKE "%dyphylline%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2641', 'drugName': 'Dyphylline', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PDE4A (ENSG00000065989), PDE4D (ENSG00000113448), PDE4B (ENSG00000184588), PDE4C (ENSG00000105650), PDE3A (ENSG00000172572)', 'yearOfFirstApproval': 1951, 'maxClinicalTrialPhase': 4, 'drugIs... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1529 | Q59 | What is the genetic target of the small molecule drug Oxprenolol Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Oxprenolol Hydrochloride: ADRB1 and ADRB2. Oxprenolol Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%oxprenolol hydrochloride%" OR LOWER(tradeNames_string) LIKE "%oxpren... | [{'UUID': 'DrugGeneTargets_v2_152', 'drugName': 'Oxprenolol Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB1 (ENSG00000043591), ADRB2 (ENSG00000169252)', 'yearOfFirstApproval': 1983, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_153', 'drugName... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.627 | Q59 | What is the genetic target of the small molecule drug Conivaptan, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Conivaptan: AVPR2 and AVPR1A. Conivaptan reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%conivaptan%" OR LOWER(tradeNames_string) LIKE "%conivaptan%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2594', 'drugName': 'Conivaptan', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AVPR2 (ENSG00000126895), AVPR1A (ENSG00000166148)', 'yearOfFirstApproval': 2005, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2593', 'drugName': 'Conivap... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1991 | Q59 | What is the genetic target of the small molecule drug Clomipramine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Clomipramine is SLC6A4. Clomipramine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%clomipramine%" OR LOWER(tradeNames_string) LIKE "%clomipramine%" OR ... | [{'UUID': 'DrugGeneTargets_v2_4905', 'drugName': 'Clomipramine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A4 (ENSG00000108576)', 'yearOfFirstApproval': 1989, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1137', 'drugName': 'Clomipramine Hydrochloride', '... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.813 | Q59 | What is the genetic target of the small molecule drug Pheniramine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Pheniramine is HRH1. Pheniramine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pheniramine%" OR LOWER(tradeNames_string) LIKE "%pheniramine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3635', 'drugName': 'Dexchlorpheniramine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1981, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1578', 'drugName': 'Pheniramine', 'drugMolecu... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.309 | Q59 | What is the genetic target of the small molecule drug Aminocaproic Acid, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Aminocaproic Acid: PLAT and PLG. Aminocaproic Acid reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%aminocaproic acid%" OR LOWER(tradeNames_string) LIKE "%aminocaproic ... | [{'UUID': 'DrugGeneTargets_v2_5590', 'drugName': 'Aminocaproic Acid', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PLAT (ENSG00000104368), PLG (ENSG00000122194)', 'yearOfFirstApproval': 1964, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5591', 'drugName': 'Amin... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.550 | Q59 | What is the genetic target of the small molecule drug Rodatristat Ethyl, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Rodatristat Ethyl is TPH1. Rodatristat Ethyl reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rodatristat ethyl%" OR LOWER(tradeNames_string) LIKE "%rodatristat e... | [{'UUID': 'DrugGeneTargets_v2_1600', 'drugName': 'Rodatristat Ethyl', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TPH1 (ENSG00000129167)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.